SEC Tracker
Get the app

Lantern Pharma LTRN

Lantern Pharma: proxy statement

Form
DEF 14A
Filed
Period
Importance
Routine
Document
DEF 14A

Not explained yet; the original is on EDGAR.

Proxy statement

View on EDGAR

Open in the app

Get an email when Lantern Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Kezar Life Sciences KZR public float $33M, Jun 30, 2025
  2. Grace Therapeutics GRCE public float $35M, Sep 30, 2025
  3. Insight Molecular Diagnostics IMDX public float $32M, Jun 30, 2025
  4. Rein Therapeutics RNTX public float $32M, Jun 30, 2025
  5. Yarrow Bioscience VYNE public float $32M, Jun 30, 2025